Core Viewpoint - The company, 泰德医药 (03880), has received a filing notice from the China Securities Regulatory Commission (CSRC) regarding its conversion and listing, indicating that the filing process has been completed [1] Group 1: Filing and Listing Process - The company received the filing notice on February 5, 2026, confirming the completion of the CSRC filing for conversion and listing [1] - If the company does not complete the share conversion within 12 months from the date of the filing notice, it must update the filing materials to the CSRC for further progress [1] - Details regarding the implementation plan for the conversion and listing have not yet been finalized as of the announcement date [1] Group 2: Compliance and Future Announcements - The company will make further announcements regarding the progress of the conversion and listing in accordance with listing rules and applicable laws and regulations [1]
泰德医药：中国证监会就公司H股全流通申请发出备案通知书